Singapore: Astellas pharma recently announced collaboration with Immunomic Therapeutics to develop and commercialize JRC...
Singapore: Pharmaceutical companies will suffer an estimated $65 billion drop in sales by 2019 worldwide due to the pate...
Singapore: Astellas Pharma and UMN Pharma have highlighted that the summary results for phase III clinical trial showed...
Singapore: Japanese Ministry of Health, Labour and Welfare (MHLW) has approved Novartis' Cosentyx (secukinumab, formerly...
Singapore: Type 2 diabetes treatment market in Asia-Pacific (APAC) will rise in value from an estimated $6.5 billion in ...
Singapore: Medidata, a global provider of cloud-based solutions for clinical research in life science industry, recently...
Singapore: Forging its relationship with Takeda further, Mersana Therapeutics has inked a pact to develop targeted cance...
Nasdaq-listed Neurocrine Biosciences has entered into an exclusive collaboration and licensing agreement for the develop...
Tokyo: Japan's Daiichi Sankyo Company Limited has announced details of the application for its Take a New Challenge for ...
Singapore: Almac, a global clinical trial solution provider, is expanding clinical services and technologies capabilitie...
Singapore: Pharmaceutical Product Development (PPD) and Japan based Shin Nippon Biomedical Laboratories (SNBL) have form...
Singapore: Japan-based Takeda Pharmaceutical has decided to acquire Brazil-based Multilab. Takeda expects that the trans...
Singapore: Japan's Tokai Pharmaceuticals, a clinical-stage biopharmaceutical company focused on developing novel therapi...
Singapore: Hitachi Aloka Medical announced that they have introduced an advanced versatile ultrasound, Noblus. Diagnost...
Singapore: Ranbaxy Laboratories, which is already reeling under several regulatory rebukes owing to quality apprehension...
Singapore: Japan partially suspended imports of wheat from the US on Friday after the US government revealed that a stra...
Singapore: Takeda Pharmaceutical Company announced that Takeda's wholly-owned subsidiary, Takeda Pharmaceuticals US (TP...
Singapore: Eisai has established a new pharmaceutical sales subsidiary in Moscow, Russia, which will be named a limited...
